Edition:
United States

Genomic Health Inc (GHDX.OQ)

GHDX.OQ on NASDAQ Stock Exchange Global Select Market

64.40USD
19 Oct 2018
Change (% chg)

$-3.56 (-5.24%)
Prev Close
$67.96
Open
$68.23
Day's High
$69.47
Day's Low
$64.19
Volume
84,390
Avg. Vol
115,277
52-wk High
$72.27
52-wk Low
$26.54

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 95.62 0.227
Mar '18 92.62 -0.107
FY 2017 Dec '17 87.46 0.054
Sep '17 83.82 -0.063
Jun '17 85.49 -0.080
Mar '17 83.98 -0.024
FY 2016 Dec '16 82.74 0.040
Sep '16 82.26 -0.084
Jun '16 81.97 -0.184
Mar '16 80.89 -0.193
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 8 98.37 100.00 96.53 100.05
Quarter Ending Mar-19 6 101.20 103.90 96.64 104.00
Year Ending Dec-18 8 381.17 383.10 379.00 388.70
Year Ending Dec-19 8 421.97 435.10 407.50 424.29
Earnings (per share)
Quarter Ending Dec-18 8 0.09 0.17 0.02 0.13
Quarter Ending Mar-19 7 0.14 0.20 0.09 0.12
Year Ending Dec-18 1 0.56 0.56 0.56 0.35
Year Ending Dec-19 8 0.85 1.53 0.47 0.64
LT Growth Rate (%) 1 361.10 361.10 361.10 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 589.20 119.85 32.14
P/E High - Last 5 Yrs. -- 284.29 46.82
P/E Low - Last 5 Yrs. -- 95.75 24.71
Beta 0.54 0.63 0.87
Price to Sales (TTM) 6.46 109.82 6.55
Price to Book (MRQ) 10.01 13.72 4.00
Price to Tangible Book (MRQ) 10.32 20.21 6.10
Price to Cash Flow (TTM) 138.47 69.50 21.51
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.68
Dividend Yield - 5 Year Avg -- 0.20 1.45
Dividend 5 Year Growth Rate -- 2.61 -5.91
Payout Ratio(TTM) 0.00 5.68 46.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 11.85 157.56 7.91
Sales (TTM) vs TTM 1 Yr. Ago 7.49 91.25 6.56
Sales - 5 Yr. Growth Rate 7.70 25.47 7.49
EPS (MRQ) vs Qtr. 1 Yr. Ago 384.72 297.15 26.63
EPS (TTM) vs TTM 1 Yr. Ago 174.56 -- --
EPS - 5 Yr. Growth Rate -- 25.12 7.65
Capital Spending - 5 Yr. Growth Rate 5.71 39.11 8.16

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.22
Current Ratio (MRQ) 5.39 5.52 2.99
LT Debt to Equity (MRQ) 0.00 15.33 11.31
Total Debt to Equity (MRQ) 0.00 18.80 14.15
Interest Coverage (TTM) -- -216.32 34.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 83.25 32.64 54.36
Gross Margin - 5 Yr. Avg. 82.82 52.76 53.16
EBITD Margin (TTM) 4.11 -- --
EBITD - 5 Yr. Avg -3.38 -164.07 16.13
Operating Margin (TTM) 0.62 -618.88 3.36
Operating Margin - 5 Yr. Avg. -6.16 -178.92 11.28
Pre-Tax Margin (TTM) 1.39 -615.68 3.79
Pre-Tax Margin - 5 Yr. Avg. -5.75 -181.48 11.54
Net Profit Margin (TTM) 1.18 -604.79 0.60
Net Profit Margin - 5 Yr. Avg. -5.92 -179.91 7.83
Effective Tax Rate (TTM) 15.26 11.98 20.73
Effective Tax Rate - 5 Yr. Avg. -- 19.65 24.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 416,603 24,741,437 725,680,242
Net Income/Employee (TTM) 4,902 1,102,410 84,001,075
Receivable Turnover (TTM) 8.83 4.18 5.06
Inventory Turnover (TTM) -- 2.14 3.65
Asset Turnover (TTM) 1.49 0.39 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 1.76 0.35 9.83
Return on Assets - 5 Yr. Avg. -9.39 3.11 10.94
Return on Investment (TTM) 2.10 1.96 12.83
Return on Investment - 5 Yr. Avg. -11.68 2.91 14.05
Return on Equity (TTM) 2.14 1.12 14.95
Return on Equity - 5 Yr. Avg. -11.90 -0.97 15.39
  1 Year 3 Year 5 Year
Sales % 3.93 7.32 7.70
EPS (TTM) % 73.28 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Genomic Health Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 1.36 1.10 73 59
13 Week 30.57 26.03 91 76
26 Week 109.51 89.80 96 56
52 Week 96.13 73.34 90 83
YTD 89.47 75.63 92 84
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 91.88%
# of Holders: 240
Total Shares Held: 32,945,247
3 Mo. Net Change: 289,762
# New Positions: 7
# Closed Positions: 1
# Increased Positions: 19
# Reduced Positions: 4
# Net Buyers: 15
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.